Skip to content

Technology-assisted Language Intervention (TALI)

Technology-assisted Language Intervention for Children Who Are Deaf/Hard-of-hearing (TALI)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04857255
Acronym
TALI
Enrollment
143
Registered
2021-04-23
Start date
2020-10-15
Completion date
2026-03-31
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Bilateral, Language Development

Keywords

hearing loss, randomized clinical trial, intervention, language development

Brief summary

This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized to receive either the technology intervention or treatment as usual

Interventions

BEHAVIORALTechnology assisted language intervention

speech language therapy that has integrated technology delivered through specific software on an iPad

BEHAVIORALTreatment as usual

No change will occur to the current ongoing speech-language therapy being delivered.

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 3-10 years * Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound). * Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient \<.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive. * Currently receiving speech-language therapy.

Exclusion criteria

Mild hearing loss and unilateral hearing loss * primary language other than English * significant motor impairments * nonverbal IQ \<80 * children with severe communication disorders (i.e. autism spectrum disorders).

Design outcomes

Primary

MeasureTime frameDescription
Mean Length of Utterance in morphemes24 weeksMeasurement of syntax
Mean Turn Length24 weeksMeasurement of discourse
Number of different vocabulary words spoken24 weeksmeasure of semantics
Clinical Evaluation of Language Fundamentals-5th edition24 weeksProvides receptive and expressive standard scores on a scale with a mean of 100 +/- 15standard deviations; higher scores indicate better/higher language skills

Secondary

MeasureTime frameDescription
Expressive Vocabulary Test 2nd edition24 weeksProvides expressive vocabulary standard scores on a scale with a mean of 100 +/- 15standard deviations; higher scores indicate better/higher vocabulary skills
Clinical Evaluation of Language Fundamentals-5th edition-pragmatics profile24 weeksProvides pragmatic language scores as scaled scores (ranging from 1 to 15), age equivalents and percentile ranks

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJareen Meinzen-Derr

Children's Hospital Medical Center, Cincinnati

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026